Amgen (AMGN) R&D/CAPEX US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 691.9% 547.6% 473.7% 473.7% 430.2%   590.6%  
Changes by years, y/y, % +26pp -144pp -74pp 0pp -44pp     -3.2%

Amgen. R&D/CAPEX, %

Amgen. R&D/CAPEX, changes, pp

Amgen (AMGN) R&D/CAPEX US GAAP (quarter values)

2023Q4 2024Q1 2024Q2 2024Q2 2024Q3   LTM ?
R&D/CAPEX, % 616.1% 583.9% 608.0% 608.0% 564.2%   590.6%
Changes by years, y/y, % +227pp +276pp +197pp +197pp +129pp    
Changes by quarters, q/q, % 0pp -32pp +24pp 0pp -44pp    

Amgen. R&D/CAPEX, %

Amgen. R&D/CAPEX, changes, pp

Amgen. R&D/CAPEX, changes, pp